204 filings
Page 5 of 11
8-K
k029a97
19 Dec 06
Departure of Directors or Principal Officers
12:00am
8-K/A
78iroo
19 Dec 06
Cost Associated with Exit or Disposal Activities
12:00am
8-K
d9i wcp9h1bz5
14 Nov 06
Other Events
12:00am
8-K
1q0w0rnh5 23uwixnas
8 Nov 06
OSI Pharmaceuticals Announces Third Quarter 2006 Financial Results
12:00am
8-K
0hewt
20 Oct 06
OSI Pharmaceuticals Announces Conversion Period for Convertible Notes
12:00am
8-K
nip3n 7dpy586oyymwbj
17 Oct 06
Other Events
12:00am
8-K
19r pnrm51
11 Oct 06
Other Events
12:00am
8-K
l1g6rmej gfu8b7f
21 Sep 06
Osi Pharmaceuticals Launches Study of TarcevaĆ¢as Adjuvant Treatment for Non-small Cell Lung Cancer
12:00am
8-K
9zsiy5immqa
9 Aug 06
OSI Pharmaceuticals Announces Second Quarter 2006 Financial Results
12:00am
8-K
pyg6htamau 9fkj1
20 Jul 06
Other Events
12:00am
8-K
z07nydbolxuq
12 Jul 06
Entry into a Material Definitive Agreement
12:00am
8-K
s892wu1c541v8n
12 Jul 06
Other Events
12:00am
8-K
jt50r 77j66z
6 Jul 06
Entry into a Material Definitive Agreement
12:00am
8-K
v2o1gfzzlhn
22 Jun 06
Entry into a Material Definitive Agreement
12:00am
8-K
7r2 tkne0wzw
16 Jun 06
Encouraging Pre-Clinical Data From Diabetes/Obesity Program Also Presented
12:00am
8-K
gyx sx92c
6 Jun 06
Other Events
12:00am
8-K
dvgot
12 May 06
OSI Pharmaceuticals Announces First Quarter 2006 Financial Results
12:00am
8-K
suac1ol168p3nr gq
8 May 06
Other Events
12:00am
8-K
1e8q yv2vtag7k4jqtw
3 May 06
OSI Pharmaceuticals Announces Management Changes to its Eye Disease Business Team
12:00am
8-K
jtbhbq5 a19m04
27 Apr 06
Other Events
12:00am